CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sanofi-Aventis Deutschland GMBH v. Novo Nordisk Inc

9:09-cv-00009

Overview

Case Number 9:09-cv-00009
Filing Date 2009-01-09
Status Litigation filed
Court District Court, E.D. Texas (txed)
Nature of Suit 830 Patent
Cause of Action 15:1126 Patent Infringement

Parties

Defendant

Novo Nordisk Inc

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Sanofi-Aventis Deutschland GMBH

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, E.D. Texas (txed)

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Docket Entries

COMPLAINT against Novo Nordisk Inc ( Filing fee $ 350 receipt number 05400000000001829241.), filed by Sanofi-Aventis Deutschland GMBH. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet)(Smith, Jim) (Entered: 01/09/2009)

2009-01-09
1

CORPORATE DISCLOSURE STATEMENT filed by Sanofi-Aventis Deutschland GMBH identifying Corporate Parent Sanofi-Aventis, Other Affiliate Total SA, Other Affiliate L'oreal for Sanofi-Aventis Deutschland GMBH. (Smith, Jim) (Entered: 01/09/2009)

2009-01-09
1

Notice of Filing of Patent/Trademark Form (AO 120). AO 120 mailed to the Director of the U.S. Patent and Trademark Office. (Smith, Jim) (Entered: 01/09/2009)

2009-01-09
1

E-GOV SEALED SUMMONS Issued as to Novo Nordisk Inc. and emailed back to atty of record for service (djh, ) (Entered: 01/09/2009)

2009-01-09
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc